Corcept Therapeutics Inc (NASDAQ:CORT) Director G Leonard Baker, Jr. purchased 103,386 shares of the company stock on the open market in a transaction dated Wednesday, June 11th. The shares were purchased at an average cost of $2.32 per share, with a total value of $239,855.52. Following the acquisition, the director now directly owns 578,389 shares in the company, valued at approximately $1,341,862. On Monday, shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) dropped -6.94% to close the day at $2.28. Company return on investment (ROI) is -74.10% and its monthly performance is recorded as 18.75%. Corcept Therapeutics Incorporated (NASDAQ:CORT) quarterly revenue growth is -38.21%.